Erudio Healtherudio.com
Drug
capecitabine
1 HCP commentary report on clinical trials studying capecitabine. Each report covers what clinicians said in public about one trial, with the source behind every view.
| Trial | Indication | Phase | Statements | HCP sources | Size | Updated | Preview |
|---|---|---|---|---|---|---|---|
| KEYNOTE-B49 NCT04895358 · Merck Sharp & Dohme LLC | HR+/HER2- locally recurrent inoperable or metastatic breast cancer | Phase 3 | 74 | 40 | Focused | Oct 31, 2026 | Preview |